Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

  136,880,248      
Direct Value   $2,490,637,717    

Indirect Value

  $7,464,070,827      
Total Shares   186,710,189      
Total Value   $9,954,708,545      


Neurocrine Biosciences Inc
 $708,373,718 Neurobiological Technologies Inc
 $0 Epirus Biopharmaceuticals Inc
 $7 Adolor Corp
 $0 Dynavax Technologies Corp
 $50,704,384 Ligand Pharmaceuticals Inc
 $1,288,080,455 Curis Inc
 $3,390,252 Repligen Corp
 $439,034,639 Gyre Therapeutics
 $1,054,262 Neurocrine Biosciences Inc
 $708,373,718 Neurobiological Technologies Inc
 $0 Epirus Biopharmaceuticals Inc
 $7 Adolor Corp
 $0 Dynavax Technologies Corp
 $50,704,384 Ligand Pharmaceuticals Inc
 $1,288,080,455 Curis Inc
 $3,390,252 Repligen Corp
 $439,034,639 Gyre Therapeutics
 $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    19   
    2    

     Stock price went up :

    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2009-07-01 4 S $2.97 $423,633 D/D (142,700) 15,169,950 0 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-23 4 B $3.22 $426,099 I/I 132,300 4,710,132 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-06 4 B $5.00 $433,162 I/I 86,700 4,168,400 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-10-15 4 B $0.65 $462,800 I/I 712,000 5,796,799 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-03-10 4 B $3.73 $469,350 I/I 126,000 4,608,215 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-28 4 B $1.99 $479,612 I/I 240,600 13,060,253 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-03 4 B $4.93 $483,013 I/I 98,000 4,058,500 1.5 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-07-27 4 S $1.99 $488,215 D/D (245,100) 6,068,557 0 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-07-07 4 B $4.24 $490,718 I/I 115,700 5,208,200 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-21 4 B $4.70 $498,582 I/I 106,000 3,340,300 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-15 4 B $4.65 $498,655 I/I 107,300 6,062,877 1.5 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-07-01 4 S $5.42 $514,900 I/I (95,000) 1,395,351 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-10-07 4 B $0.66 $518,003 I/I 790,000 4,897,899 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-07 4 B $4.99 $521,912 I/I 104,600 4,273,000 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-09 4 B $4.29 $525,966 I/I 122,700 5,606,550 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-25 4 B $4.96 $535,205 I/I 108,000 3,527,300 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-03-07 4 B $3.81 $556,057 I/I 146,100 4,482,215 1.5 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-01-20 4 S $6.00 $570,000 I/I (95,000) 1,580,351 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-01-14 4 S $6.05 $574,750 I/I (95,000) 1,626,351 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-05-15 4 B $4.63 $584,453 I/I 126,300 5,001,400 1.5 -
CAPS Capstone Therapeutics Cor... Indirect Beneficial Owner   –       –       •   2008-10-14 4 B $0.63 $598,083 I/I 946,500 5,136,888 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-25 4 B $1.77 $625,481 I/I 353,000 11,469,653 1.5 -
AMAG AMAG Pharmaceuticals Inc officerTitle   –       –       •   2005-01-13 4 S $15.40 $670,978 I/I (43,570) 985,163 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-23 4 B $4.47 $690,969 I/I 154,600 6,217,477 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-11 4 B $4.90 $694,267 I/I 141,800 4,639,800 1.5 -

  195  Records found
  1   2   3   4   5   6  7   8      
  Page 6 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed